【SUMMARY】

Chirwere cheHepatitis C (HCV) chave kuzivikanwa sechirwere chikuru chehepatitis, kuwedzerwa ropa kusiri maratidziro ezve maantigens ari muhurongwa hwemabhakitiriya seE.coli uye akanangana nemaitiro uye asiri e-zvimiro matunhu eHCV-encoded polyprotein, ari zvechokwadi immunogenic.Maantigens makuru ekudzivirira zvirwere emapuroteni aya akanzi akakosha,NS3,NS4 neNS5 anonyanya kuzivikanwa munzvimbo dziri pedyo neHCV. Pakuonekwa kuti une utachiona hweHCV, mapuroteni akashandiswa patsva akashandiswa sezvishandiswa zvekutora bvunzo dze immunochromatographic (rapid) test.Tichienzanisa neyekutanga HCV bvunzo tichishandisa single recombinant antigens, maantigen akawanda anoshandisa mapuroteni anodzokororwa akawedzerwa muongororo itsva dze serologic kudzivirira kusanganisa kusingatarisike-kuita uye kuwedzera kunzwisiswa kweHCV.

【KUNZWISISA】

Iyo recombinant antigen inoshandiswa paHCV Rapid Test Device (Serum/Plasma/Whole ropa) inovharwa nemajini ezvose zviri zviviri (nucleocapsid) uye asiri - HCV Rapid Test Device (Serum/Plasma/Whole blood) yakapfuura seroconversion panel uye yakaenzanisa nemukurumbira weHCV EIA bvunzo pachishandiswa kliniki specimens.Zvabuda zvinoratidza kuti relative sensitivity yeHCV Rapid Test Device(Serum/Plasma/Whole ropa) i99.99%, uye 799 %.